Mid-Atlantic Home Health Network, Inc.
Mid-Atlantic Home Health Network, Inc. (MAHN) Stock Competitors & Peer Comparison
See (MAHN) competitors and their performances in Stock Market.
Peer Comparison Table: Medical - Care Facilities Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| MAHN | $0.00 | +0.00% | 1.2K | 0.05 | $0.00 | N/A |
| FSNUY | $12.17 | -1.97% | 110.1B | 22.22 | $0.55 | +2.25% |
| FSNUF | $46.21 | +0.00% | 28B | 21.00 | $2.20 | +2.28% |
| KONEF | $0.01 | +49899.62% | 22.2B | -0.12 | -$0.04 | N/A |
| JDHIY | $5.69 | +11.57% | 18.2B | 31.61 | $0.18 | N/A |
| FMCQF | $47.20 | -9.49% | 13.8B | 19.03 | $2.48 | +3.46% |
| BDUUY | $32.26 | -0.22% | 12.8B | 28.30 | $1.14 | +2.79% |
| JDHIF | $3.65 | -41.80% | 11.7B | 20.28 | $0.18 | N/A |
| BDULF | $0.61 | +0.67% | 9.8B | 20.47 | $0.03 | +3.61% |
| IHHHF | $1.10 | -7.56% | 9.7B | 15.71 | $0.07 | +5.28% |
Stock Comparison
MAHN vs FSNUY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, FSNUY has a market cap of 110.1B. Regarding current trading prices, MAHN is priced at $0.00, while FSNUY trades at $12.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas FSNUY's P/E ratio is 22.22. In terms of profitability, MAHN's ROE is N/A, compared to FSNUY's ROE of +0.02%. Regarding short-term risk, MAHN is more volatile compared to FSNUY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check FSNUY's competition here
MAHN vs FSNUF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, FSNUF has a market cap of 28B. Regarding current trading prices, MAHN is priced at $0.00, while FSNUF trades at $46.21.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas FSNUF's P/E ratio is 21.00. In terms of profitability, MAHN's ROE is N/A, compared to FSNUF's ROE of +0.02%. Regarding short-term risk, MAHN is more volatile compared to FSNUF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check FSNUF's competition here
MAHN vs KONEF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, KONEF has a market cap of 22.2B. Regarding current trading prices, MAHN is priced at $0.00, while KONEF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas KONEF's P/E ratio is -0.12. In terms of profitability, MAHN's ROE is N/A, compared to KONEF's ROE of -6.56%. Regarding short-term risk, MAHN is less volatile compared to KONEF. This indicates potentially lower risk in terms of short-term price fluctuations for MAHN.Check KONEF's competition here
MAHN vs JDHIY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, JDHIY has a market cap of 18.2B. Regarding current trading prices, MAHN is priced at $0.00, while JDHIY trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas JDHIY's P/E ratio is 31.61. In terms of profitability, MAHN's ROE is N/A, compared to JDHIY's ROE of +0.05%. Regarding short-term risk, MAHN is more volatile compared to JDHIY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check JDHIY's competition here
MAHN vs FMCQF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, FMCQF has a market cap of 13.8B. Regarding current trading prices, MAHN is priced at $0.00, while FMCQF trades at $47.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas FMCQF's P/E ratio is 19.03. In terms of profitability, MAHN's ROE is N/A, compared to FMCQF's ROE of +0.04%. Regarding short-term risk, MAHN is more volatile compared to FMCQF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check FMCQF's competition here
MAHN vs BDUUY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BDUUY has a market cap of 12.8B. Regarding current trading prices, MAHN is priced at $0.00, while BDUUY trades at $32.26.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BDUUY's P/E ratio is 28.30. In terms of profitability, MAHN's ROE is N/A, compared to BDUUY's ROE of +0.16%. Regarding short-term risk, MAHN is more volatile compared to BDUUY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BDUUY's competition here
MAHN vs JDHIF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, JDHIF has a market cap of 11.7B. Regarding current trading prices, MAHN is priced at $0.00, while JDHIF trades at $3.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas JDHIF's P/E ratio is 20.28. In terms of profitability, MAHN's ROE is N/A, compared to JDHIF's ROE of +0.05%. Regarding short-term risk, MAHN is more volatile compared to JDHIF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check JDHIF's competition here
MAHN vs BDULF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BDULF has a market cap of 9.8B. Regarding current trading prices, MAHN is priced at $0.00, while BDULF trades at $0.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BDULF's P/E ratio is 20.47. In terms of profitability, MAHN's ROE is N/A, compared to BDULF's ROE of +0.16%. Regarding short-term risk, MAHN is more volatile compared to BDULF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BDULF's competition here
MAHN vs IHHHF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, IHHHF has a market cap of 9.7B. Regarding current trading prices, MAHN is priced at $0.00, while IHHHF trades at $1.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas IHHHF's P/E ratio is 15.71. In terms of profitability, MAHN's ROE is N/A, compared to IHHHF's ROE of +0.08%. Regarding short-term risk, MAHN is more volatile compared to IHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check IHHHF's competition here
MAHN vs BDUUF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BDUUF has a market cap of 9.6B. Regarding current trading prices, MAHN is priced at $0.00, while BDUUF trades at $0.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BDUUF's P/E ratio is 20.12. In terms of profitability, MAHN's ROE is N/A, compared to BDUUF's ROE of +0.16%. Regarding short-term risk, MAHN is more volatile compared to BDUUF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BDUUF's competition here
MAHN vs WFHG Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, WFHG has a market cap of 6.6B. Regarding current trading prices, MAHN is priced at $0.00, while WFHG trades at $103.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas WFHG's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to WFHG's ROE of +0.22%. Regarding short-term risk, MAHN is more volatile compared to WFHG. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check WFHG's competition here
MAHN vs RMSYF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RMSYF has a market cap of 5.9B. Regarding current trading prices, MAHN is priced at $0.00, while RMSYF trades at $25.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RMSYF's P/E ratio is 510.20. In terms of profitability, MAHN's ROE is N/A, compared to RMSYF's ROE of +0.18%. Regarding short-term risk, MAHN is more volatile compared to RMSYF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RMSYF's competition here
MAHN vs RMYHY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RMYHY has a market cap of 5B. Regarding current trading prices, MAHN is priced at $0.00, while RMYHY trades at $5.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RMYHY's P/E ratio is 535.00. In terms of profitability, MAHN's ROE is N/A, compared to RMYHY's ROE of +0.18%. Regarding short-term risk, MAHN is more volatile compared to RMYHY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RMYHY's competition here
MAHN vs BUHPF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BUHPF has a market cap of 4.9B. Regarding current trading prices, MAHN is priced at $0.00, while BUHPF trades at $6.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BUHPF's P/E ratio is 25.67. In terms of profitability, MAHN's ROE is N/A, compared to BUHPF's ROE of +0.28%. Regarding short-term risk, MAHN is more volatile compared to BUHPF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BUHPF's competition here
MAHN vs ANHGY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, ANHGY has a market cap of 4B. Regarding current trading prices, MAHN is priced at $0.00, while ANHGY trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas ANHGY's P/E ratio is 23.87. In terms of profitability, MAHN's ROE is N/A, compared to ANHGY's ROE of N/A. Regarding short-term risk, MAHN is more volatile compared to ANHGY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check ANHGY's competition here
MAHN vs BUGDF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BUGDF has a market cap of 3.4B. Regarding current trading prices, MAHN is priced at $0.00, while BUGDF trades at $4.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BUGDF's P/E ratio is 15.67. In terms of profitability, MAHN's ROE is N/A, compared to BUGDF's ROE of +0.28%. Regarding short-term risk, MAHN is more volatile compared to BUGDF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BUGDF's competition here
MAHN vs RHCGF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RHCGF has a market cap of 3.2B. Regarding current trading prices, MAHN is priced at $0.00, while RHCGF trades at $3.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RHCGF's P/E ratio is -8.41. In terms of profitability, MAHN's ROE is N/A, compared to RHCGF's ROE of -0.07%. Regarding short-term risk, MAHN is more volatile compared to RHCGF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RHCGF's competition here
MAHN vs MCVEY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, MCVEY has a market cap of 2.8B. Regarding current trading prices, MAHN is priced at $0.00, while MCVEY trades at $21.54.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas MCVEY's P/E ratio is 52.54. In terms of profitability, MAHN's ROE is N/A, compared to MCVEY's ROE of +0.06%. Regarding short-term risk, MAHN is more volatile compared to MCVEY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check MCVEY's competition here
MAHN vs MCVEF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, MCVEF has a market cap of 2.7B. Regarding current trading prices, MAHN is priced at $0.00, while MCVEF trades at $18.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas MCVEF's P/E ratio is 75.00. In terms of profitability, MAHN's ROE is N/A, compared to MCVEF's ROE of +0.06%. Regarding short-term risk, MAHN is more volatile compared to MCVEF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check MCVEF's competition here
MAHN vs JXFGF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, JXFGF has a market cap of 2.7B. Regarding current trading prices, MAHN is priced at $0.00, while JXFGF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas JXFGF's P/E ratio is 50.00. In terms of profitability, MAHN's ROE is N/A, compared to JXFGF's ROE of +0.03%. Regarding short-term risk, MAHN is more volatile compared to JXFGF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check JXFGF's competition here
MAHN vs TTALF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, TTALF has a market cap of 1.6B. Regarding current trading prices, MAHN is priced at $0.00, while TTALF trades at $12.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas TTALF's P/E ratio is 19.33. In terms of profitability, MAHN's ROE is N/A, compared to TTALF's ROE of +0.15%. Regarding short-term risk, MAHN is more volatile compared to TTALF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check TTALF's competition here
MAHN vs LTGHF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, LTGHF has a market cap of 1.5B. Regarding current trading prices, MAHN is priced at $0.00, while LTGHF trades at $1.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas LTGHF's P/E ratio is -25.25. In terms of profitability, MAHN's ROE is N/A, compared to LTGHF's ROE of +0.29%. Regarding short-term risk, MAHN is more volatile compared to LTGHF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check LTGHF's competition here
MAHN vs RYHTY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RYHTY has a market cap of 1.4B. Regarding current trading prices, MAHN is priced at $0.00, while RYHTY trades at $7.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RYHTY's P/E ratio is -3.79. In terms of profitability, MAHN's ROE is N/A, compared to RYHTY's ROE of -0.02%. Regarding short-term risk, MAHN is more volatile compared to RYHTY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RYHTY's competition here
MAHN vs RAFLF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RAFLF has a market cap of 1.4B. Regarding current trading prices, MAHN is priced at $0.00, while RAFLF trades at $0.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RAFLF's P/E ratio is 25.00. In terms of profitability, MAHN's ROE is N/A, compared to RAFLF's ROE of +0.04%. Regarding short-term risk, MAHN is more volatile compared to RAFLF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RAFLF's competition here
MAHN vs LWSCF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, LWSCF has a market cap of 1.2B. Regarding current trading prices, MAHN is priced at $0.00, while LWSCF trades at $13.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas LWSCF's P/E ratio is 43.73. In terms of profitability, MAHN's ROE is N/A, compared to LWSCF's ROE of +0.07%. Regarding short-term risk, MAHN is more volatile compared to LWSCF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check LWSCF's competition here
MAHN vs LTGHY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, LTGHY has a market cap of 1.1B. Regarding current trading prices, MAHN is priced at $0.00, while LTGHY trades at $2.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas LTGHY's P/E ratio is -19.63. In terms of profitability, MAHN's ROE is N/A, compared to LTGHY's ROE of +0.40%. Regarding short-term risk, MAHN is more volatile compared to LTGHY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check LTGHY's competition here
MAHN vs RHKJF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RHKJF has a market cap of 1B. Regarding current trading prices, MAHN is priced at $0.00, while RHKJF trades at $15.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RHKJF's P/E ratio is 21.55. In terms of profitability, MAHN's ROE is N/A, compared to RHKJF's ROE of +0.03%. Regarding short-term risk, MAHN is more volatile compared to RHKJF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RHKJF's competition here
MAHN vs RKAGY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RKAGY has a market cap of 986.7M. Regarding current trading prices, MAHN is priced at $0.00, while RKAGY trades at $7.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RKAGY's P/E ratio is 21.06. In terms of profitability, MAHN's ROE is N/A, compared to RKAGY's ROE of +0.03%. Regarding short-term risk, MAHN is more volatile compared to RKAGY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RKAGY's competition here
MAHN vs NWKHY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NWKHY has a market cap of 950.7M. Regarding current trading prices, MAHN is priced at $0.00, while NWKHY trades at $7.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NWKHY's P/E ratio is 11.47. In terms of profitability, MAHN's ROE is N/A, compared to NWKHY's ROE of +0.13%. Regarding short-term risk, MAHN is more volatile compared to NWKHY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NWKHY's competition here
MAHN vs WHTCF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, WHTCF has a market cap of 879.7M. Regarding current trading prices, MAHN is priced at $0.00, while WHTCF trades at $3.48.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas WHTCF's P/E ratio is -43.44. In terms of profitability, MAHN's ROE is N/A, compared to WHTCF's ROE of -0.03%. Regarding short-term risk, MAHN is more volatile compared to WHTCF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check WHTCF's competition here
MAHN vs EXETF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, EXETF has a market cap of 754M. Regarding current trading prices, MAHN is priced at $0.00, while EXETF trades at $9.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas EXETF's P/E ratio is 13.84. In terms of profitability, MAHN's ROE is N/A, compared to EXETF's ROE of +0.66%. Regarding short-term risk, MAHN is more volatile compared to EXETF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check EXETF's competition here
MAHN vs KDGTF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, KDGTF has a market cap of 675.1M. Regarding current trading prices, MAHN is priced at $0.00, while KDGTF trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas KDGTF's P/E ratio is -1.67. In terms of profitability, MAHN's ROE is N/A, compared to KDGTF's ROE of N/A. Regarding short-term risk, MAHN is more volatile compared to KDGTF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check KDGTF's competition here
MAHN vs ORRRY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, ORRRY has a market cap of 371.5M. Regarding current trading prices, MAHN is priced at $0.00, while ORRRY trades at $0.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas ORRRY's P/E ratio is -0.33. In terms of profitability, MAHN's ROE is N/A, compared to ORRRY's ROE of +0.91%. Regarding short-term risk, MAHN is more volatile compared to ORRRY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check ORRRY's competition here
MAHN vs BTMDW Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BTMDW has a market cap of 292.9M. Regarding current trading prices, MAHN is priced at $0.00, while BTMDW trades at $1.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BTMDW's P/E ratio is 0.05. In terms of profitability, MAHN's ROE is N/A, compared to BTMDW's ROE of -0.19%. Regarding short-term risk, MAHN is more volatile compared to BTMDW. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BTMDW's competition here
MAHN vs ORPEF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, ORPEF has a market cap of 242M. Regarding current trading prices, MAHN is priced at $0.00, while ORPEF trades at $1.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas ORPEF's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to ORPEF's ROE of -0.16%. Regarding short-term risk, MAHN is less volatile compared to ORPEF. This indicates potentially lower risk in terms of short-term price fluctuations for MAHN.Check ORPEF's competition here
MAHN vs EVGRF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, EVGRF has a market cap of 234.8M. Regarding current trading prices, MAHN is priced at $0.00, while EVGRF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas EVGRF's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to EVGRF's ROE of +0.67%. Regarding short-term risk, MAHN is more volatile compared to EVGRF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check EVGRF's competition here
MAHN vs MKLNF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, MKLNF has a market cap of 217.6M. Regarding current trading prices, MAHN is priced at $0.00, while MKLNF trades at $11.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas MKLNF's P/E ratio is 19.23. In terms of profitability, MAHN's ROE is N/A, compared to MKLNF's ROE of +0.14%. Regarding short-term risk, MAHN is more volatile compared to MKLNF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check MKLNF's competition here
MAHN vs MFCSF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, MFCSF has a market cap of 207.3M. Regarding current trading prices, MAHN is priced at $0.00, while MFCSF trades at $10.89.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas MFCSF's P/E ratio is 7.06. In terms of profitability, MAHN's ROE is N/A, compared to MFCSF's ROE of +0.84%. Regarding short-term risk, MAHN is more volatile compared to MFCSF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check MFCSF's competition here
MAHN vs MDGP Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, MDGP has a market cap of 174.5M. Regarding current trading prices, MAHN is priced at $0.00, while MDGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas MDGP's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to MDGP's ROE of -2.19%. Regarding short-term risk, MAHN is less volatile compared to MDGP. This indicates potentially lower risk in terms of short-term price fluctuations for MAHN.Check MDGP's competition here
MAHN vs CHHHF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, CHHHF has a market cap of 129.2M. Regarding current trading prices, MAHN is priced at $0.00, while CHHHF trades at $2.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas CHHHF's P/E ratio is -51.25. In terms of profitability, MAHN's ROE is N/A, compared to CHHHF's ROE of -0.05%. Regarding short-term risk, MAHN is more volatile compared to CHHHF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check CHHHF's competition here
MAHN vs COLRF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, COLRF has a market cap of 124.1M. Regarding current trading prices, MAHN is priced at $0.00, while COLRF trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas COLRF's P/E ratio is -8.00. In terms of profitability, MAHN's ROE is N/A, compared to COLRF's ROE of +0.02%. Regarding short-term risk, MAHN is less volatile compared to COLRF. This indicates potentially lower risk in terms of short-term price fluctuations for MAHN.Check COLRF's competition here
MAHN vs TOKIF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, TOKIF has a market cap of 101.4M. Regarding current trading prices, MAHN is priced at $0.00, while TOKIF trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas TOKIF's P/E ratio is -0.57. In terms of profitability, MAHN's ROE is N/A, compared to TOKIF's ROE of -0.83%. Regarding short-term risk, MAHN is less volatile compared to TOKIF. This indicates potentially lower risk in terms of short-term price fluctuations for MAHN.Check TOKIF's competition here
MAHN vs VTIAF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, VTIAF has a market cap of 95.9M. Regarding current trading prices, MAHN is priced at $0.00, while VTIAF trades at $5.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas VTIAF's P/E ratio is -6.79. In terms of profitability, MAHN's ROE is N/A, compared to VTIAF's ROE of -0.63%. Regarding short-term risk, MAHN is more volatile compared to VTIAF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check VTIAF's competition here
MAHN vs MCIOF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, MCIOF has a market cap of 54M. Regarding current trading prices, MAHN is priced at $0.00, while MCIOF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas MCIOF's P/E ratio is -1.22. In terms of profitability, MAHN's ROE is N/A, compared to MCIOF's ROE of N/A. Regarding short-term risk, MAHN is more volatile compared to MCIOF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check MCIOF's competition here
MAHN vs ASSF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, ASSF has a market cap of 45.3M. Regarding current trading prices, MAHN is priced at $0.00, while ASSF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas ASSF's P/E ratio is -33.33. In terms of profitability, MAHN's ROE is N/A, compared to ASSF's ROE of -6.63%. Regarding short-term risk, MAHN is more volatile compared to ASSF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check ASSF's competition here
MAHN vs USNU Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, USNU has a market cap of 22.2M. Regarding current trading prices, MAHN is priced at $0.00, while USNU trades at $1.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas USNU's P/E ratio is -9.41. In terms of profitability, MAHN's ROE is N/A, compared to USNU's ROE of -0.62%. Regarding short-term risk, MAHN is more volatile compared to USNU. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check USNU's competition here
MAHN vs HQDA Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, HQDA has a market cap of 18.6M. Regarding current trading prices, MAHN is priced at $0.00, while HQDA trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas HQDA's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to HQDA's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to HQDA. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check HQDA's competition here
MAHN vs NVLPF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NVLPF has a market cap of 17.3M. Regarding current trading prices, MAHN is priced at $0.00, while NVLPF trades at $0.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NVLPF's P/E ratio is 19.79. In terms of profitability, MAHN's ROE is N/A, compared to NVLPF's ROE of +0.05%. Regarding short-term risk, MAHN is more volatile compared to NVLPF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NVLPF's competition here
MAHN vs FPCG Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, FPCG has a market cap of 10.3M. Regarding current trading prices, MAHN is priced at $0.00, while FPCG trades at $1,025.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas FPCG's P/E ratio is 0.09. In terms of profitability, MAHN's ROE is N/A, compared to FPCG's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to FPCG. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check FPCG's competition here
MAHN vs HLYK Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, HLYK has a market cap of 10.1M. Regarding current trading prices, MAHN is priced at $0.00, while HLYK trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas HLYK's P/E ratio is -1.78. In terms of profitability, MAHN's ROE is N/A, compared to HLYK's ROE of +2.41%. Regarding short-term risk, MAHN is more volatile compared to HLYK. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check HLYK's competition here
MAHN vs GBCS Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, GBCS has a market cap of 7.7M. Regarding current trading prices, MAHN is priced at $0.00, while GBCS trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas GBCS's P/E ratio is -3.68. In terms of profitability, MAHN's ROE is N/A, compared to GBCS's ROE of +0.56%. Regarding short-term risk, MAHN is more volatile compared to GBCS. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check GBCS's competition here
MAHN vs RHEP Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RHEP has a market cap of 7.4M. Regarding current trading prices, MAHN is priced at $0.00, while RHEP trades at $3.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RHEP's P/E ratio is -1.54. In terms of profitability, MAHN's ROE is N/A, compared to RHEP's ROE of +1.29%. Regarding short-term risk, MAHN is more volatile compared to RHEP. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RHEP's competition here
MAHN vs NUMIF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NUMIF has a market cap of 7.4M. Regarding current trading prices, MAHN is priced at $0.00, while NUMIF trades at $0.03.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NUMIF's P/E ratio is -0.38. In terms of profitability, MAHN's ROE is N/A, compared to NUMIF's ROE of -1.95%. Regarding short-term risk, MAHN is more volatile compared to NUMIF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NUMIF's competition here
MAHN vs XCRT Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, XCRT has a market cap of 6.9M. Regarding current trading prices, MAHN is priced at $0.00, while XCRT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas XCRT's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to XCRT's ROE of +2.48%. Regarding short-term risk, MAHN is more volatile compared to XCRT. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check XCRT's competition here
MAHN vs VLXC Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, VLXC has a market cap of 6.6M. Regarding current trading prices, MAHN is priced at $0.00, while VLXC trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas VLXC's P/E ratio is -9.19. In terms of profitability, MAHN's ROE is N/A, compared to VLXC's ROE of +0.58%. Regarding short-term risk, MAHN is more volatile compared to VLXC. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check VLXC's competition here
MAHN vs BICX Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BICX has a market cap of 6.5M. Regarding current trading prices, MAHN is priced at $0.00, while BICX trades at $0.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BICX's P/E ratio is -0.93. In terms of profitability, MAHN's ROE is N/A, compared to BICX's ROE of +0.40%. Regarding short-term risk, MAHN is more volatile compared to BICX. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BICX's competition here
MAHN vs RVLWF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, RVLWF has a market cap of 2.7M. Regarding current trading prices, MAHN is priced at $0.00, while RVLWF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas RVLWF's P/E ratio is -0.15. In terms of profitability, MAHN's ROE is N/A, compared to RVLWF's ROE of +3.95%. Regarding short-term risk, MAHN is more volatile compared to RVLWF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check RVLWF's competition here
MAHN vs EPWCF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, EPWCF has a market cap of 2.5M. Regarding current trading prices, MAHN is priced at $0.00, while EPWCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas EPWCF's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to EPWCF's ROE of +0.00%. Regarding short-term risk, MAHN and EPWCF have similar daily volatility (196.04).Check EPWCF's competition here
MAHN vs GRST Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, GRST has a market cap of 2.3M. Regarding current trading prices, MAHN is priced at $0.00, while GRST trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas GRST's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to GRST's ROE of +0.30%. Regarding short-term risk, MAHN is more volatile compared to GRST. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check GRST's competition here
MAHN vs SMAS Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, SMAS has a market cap of 1.5M. Regarding current trading prices, MAHN is priced at $0.00, while SMAS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas SMAS's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to SMAS's ROE of N/A. Regarding short-term risk, MAHN and SMAS have similar daily volatility (196.04).Check SMAS's competition here
MAHN vs NOVC Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NOVC has a market cap of 1.2M. Regarding current trading prices, MAHN is priced at $0.00, while NOVC trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NOVC's P/E ratio is -0.20. In terms of profitability, MAHN's ROE is N/A, compared to NOVC's ROE of +0.12%. Regarding short-term risk, MAHN is more volatile compared to NOVC. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NOVC's competition here
MAHN vs JRSS Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, JRSS has a market cap of 1.1M. Regarding current trading prices, MAHN is priced at $0.00, while JRSS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas JRSS's P/E ratio is -0.13. In terms of profitability, MAHN's ROE is N/A, compared to JRSS's ROE of +2.63%. Regarding short-term risk, MAHN is more volatile compared to JRSS. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check JRSS's competition here
MAHN vs PHMB Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, PHMB has a market cap of 1.1M. Regarding current trading prices, MAHN is priced at $0.00, while PHMB trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas PHMB's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to PHMB's ROE of N/A. Regarding short-term risk, MAHN and PHMB have similar daily volatility (196.04).Check PHMB's competition here
MAHN vs AMBD Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, AMBD has a market cap of 1M. Regarding current trading prices, MAHN is priced at $0.00, while AMBD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas AMBD's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to AMBD's ROE of +1.11%. Regarding short-term risk, MAHN is less volatile compared to AMBD. This indicates potentially lower risk in terms of short-term price fluctuations for MAHN.Check AMBD's competition here
MAHN vs ARPC Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, ARPC has a market cap of 1M. Regarding current trading prices, MAHN is priced at $0.00, while ARPC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas ARPC's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to ARPC's ROE of -0.56%. Regarding short-term risk, MAHN is more volatile compared to ARPC. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check ARPC's competition here
MAHN vs GNOW Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, GNOW has a market cap of 859.7K. Regarding current trading prices, MAHN is priced at $0.00, while GNOW trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas GNOW's P/E ratio is -0.01. In terms of profitability, MAHN's ROE is N/A, compared to GNOW's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to GNOW. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check GNOW's competition here
MAHN vs ERUC Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, ERUC has a market cap of 638.1K. Regarding current trading prices, MAHN is priced at $0.00, while ERUC trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas ERUC's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to ERUC's ROE of N/A. Regarding short-term risk, MAHN is more volatile compared to ERUC. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check ERUC's competition here
MAHN vs MSITF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, MSITF has a market cap of 480K. Regarding current trading prices, MAHN is priced at $0.00, while MSITF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas MSITF's P/E ratio is -0.10. In terms of profitability, MAHN's ROE is N/A, compared to MSITF's ROE of N/A. Regarding short-term risk, MAHN and MSITF have similar daily volatility (196.04).Check MSITF's competition here
MAHN vs NXGT Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NXGT has a market cap of 369.9K. Regarding current trading prices, MAHN is priced at $0.00, while NXGT trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NXGT's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to NXGT's ROE of +0.09%. Regarding short-term risk, MAHN is more volatile compared to NXGT. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NXGT's competition here
MAHN vs DPAT Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, DPAT has a market cap of 361.2K. Regarding current trading prices, MAHN is priced at $0.00, while DPAT trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas DPAT's P/E ratio is -1.50. In terms of profitability, MAHN's ROE is N/A, compared to DPAT's ROE of +0.45%. Regarding short-term risk, MAHN is more volatile compared to DPAT. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check DPAT's competition here
MAHN vs JNHMF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, JNHMF has a market cap of 302.9K. Regarding current trading prices, MAHN is priced at $0.00, while JNHMF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas JNHMF's P/E ratio is -0.06. In terms of profitability, MAHN's ROE is N/A, compared to JNHMF's ROE of +0.81%. Regarding short-term risk, MAHN is more volatile compared to JNHMF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check JNHMF's competition here
MAHN vs KJFI Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, KJFI has a market cap of 278.9K. Regarding current trading prices, MAHN is priced at $0.00, while KJFI trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas KJFI's P/E ratio is -0.07. In terms of profitability, MAHN's ROE is N/A, compared to KJFI's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to KJFI. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check KJFI's competition here
MAHN vs SETO Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, SETO has a market cap of 278.2K. Regarding current trading prices, MAHN is priced at $0.00, while SETO trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas SETO's P/E ratio is -2.23. In terms of profitability, MAHN's ROE is N/A, compared to SETO's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to SETO. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check SETO's competition here
MAHN vs FCHS Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, FCHS has a market cap of 241.6K. Regarding current trading prices, MAHN is priced at $0.00, while FCHS trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas FCHS's P/E ratio is -0.06. In terms of profitability, MAHN's ROE is N/A, compared to FCHS's ROE of +0.12%. Regarding short-term risk, MAHN is more volatile compared to FCHS. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check FCHS's competition here
MAHN vs DRWN Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, DRWN has a market cap of 239.8K. Regarding current trading prices, MAHN is priced at $0.00, while DRWN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas DRWN's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to DRWN's ROE of -0.01%. Regarding short-term risk, MAHN and DRWN have similar daily volatility (196.04).Check DRWN's competition here
MAHN vs BNYN Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BNYN has a market cap of 150.5K. Regarding current trading prices, MAHN is priced at $0.00, while BNYN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BNYN's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to BNYN's ROE of -14.10%. Regarding short-term risk, MAHN and BNYN have similar daily volatility (196.04).Check BNYN's competition here
MAHN vs CLRD Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, CLRD has a market cap of 140.7K. Regarding current trading prices, MAHN is priced at $0.00, while CLRD trades at $0.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas CLRD's P/E ratio is -0.01. In terms of profitability, MAHN's ROE is N/A, compared to CLRD's ROE of +0.38%. Regarding short-term risk, MAHN is more volatile compared to CLRD. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check CLRD's competition here
MAHN vs TPIA Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, TPIA has a market cap of 113.8K. Regarding current trading prices, MAHN is priced at $0.00, while TPIA trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas TPIA's P/E ratio is -0.15. In terms of profitability, MAHN's ROE is N/A, compared to TPIA's ROE of +0.60%. Regarding short-term risk, MAHN is more volatile compared to TPIA. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check TPIA's competition here
MAHN vs ACGI Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, ACGI has a market cap of 104.8K. Regarding current trading prices, MAHN is priced at $0.00, while ACGI trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas ACGI's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to ACGI's ROE of +1.11%. Regarding short-term risk, MAHN and ACGI have similar daily volatility (196.04).Check ACGI's competition here
MAHN vs SLHGF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, SLHGF has a market cap of 43.8K. Regarding current trading prices, MAHN is priced at $0.00, while SLHGF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas SLHGF's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to SLHGF's ROE of +0.00%. Regarding short-term risk, MAHN is less volatile compared to SLHGF. This indicates potentially lower risk in terms of short-term price fluctuations for MAHN.Check SLHGF's competition here
MAHN vs NMHLY Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NMHLY has a market cap of 41.7K. Regarding current trading prices, MAHN is priced at $0.00, while NMHLY trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NMHLY's P/E ratio is 0.02. In terms of profitability, MAHN's ROE is N/A, compared to NMHLY's ROE of N/A. Regarding short-term risk, MAHN is more volatile compared to NMHLY. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NMHLY's competition here
MAHN vs PRMD Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, PRMD has a market cap of 37.4K. Regarding current trading prices, MAHN is priced at $0.00, while PRMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas PRMD's P/E ratio is -0.01. In terms of profitability, MAHN's ROE is N/A, compared to PRMD's ROE of +0.73%. Regarding short-term risk, MAHN is more volatile compared to PRMD. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check PRMD's competition here
MAHN vs HSMD Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, HSMD has a market cap of 19.2K. Regarding current trading prices, MAHN is priced at $0.00, while HSMD trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas HSMD's P/E ratio is -0.01. In terms of profitability, MAHN's ROE is N/A, compared to HSMD's ROE of -0.04%. Regarding short-term risk, MAHN is more volatile compared to HSMD. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check HSMD's competition here
MAHN vs SCAL Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, SCAL has a market cap of 17.4K. Regarding current trading prices, MAHN is priced at $0.00, while SCAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas SCAL's P/E ratio is 0.04. In terms of profitability, MAHN's ROE is N/A, compared to SCAL's ROE of +0.07%. Regarding short-term risk, MAHN is more volatile compared to SCAL. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check SCAL's competition here
MAHN vs GENN Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, GENN has a market cap of 12.1K. Regarding current trading prices, MAHN is priced at $0.00, while GENN trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas GENN's P/E ratio is -0.01. In terms of profitability, MAHN's ROE is N/A, compared to GENN's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to GENN. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check GENN's competition here
MAHN vs CHCR Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, CHCR has a market cap of 12K. Regarding current trading prices, MAHN is priced at $0.00, while CHCR trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas CHCR's P/E ratio is -0.00. In terms of profitability, MAHN's ROE is N/A, compared to CHCR's ROE of N/A. Regarding short-term risk, MAHN is more volatile compared to CHCR. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check CHCR's competition here
MAHN vs CEVE Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, CEVE has a market cap of 7.7K. Regarding current trading prices, MAHN is priced at $0.00, while CEVE trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas CEVE's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to CEVE's ROE of +2.26%. Regarding short-term risk, MAHN is more volatile compared to CEVE. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check CEVE's competition here
MAHN vs NAFS Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NAFS has a market cap of 7K. Regarding current trading prices, MAHN is priced at $0.00, while NAFS trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NAFS's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to NAFS's ROE of +1.02%. Regarding short-term risk, MAHN is more volatile compared to NAFS. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NAFS's competition here
MAHN vs NRTSF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NRTSF has a market cap of 7K. Regarding current trading prices, MAHN is priced at $0.00, while NRTSF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NRTSF's P/E ratio is 0.00. In terms of profitability, MAHN's ROE is N/A, compared to NRTSF's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to NRTSF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NRTSF's competition here
MAHN vs MSGP Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, MSGP has a market cap of 5.2K. Regarding current trading prices, MAHN is priced at $0.00, while MSGP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas MSGP's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to MSGP's ROE of +0.27%. Regarding short-term risk, MAHN is more volatile compared to MSGP. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check MSGP's competition here
MAHN vs PAOG Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, PAOG has a market cap of 5K. Regarding current trading prices, MAHN is priced at $0.00, while PAOG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas PAOG's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to PAOG's ROE of +0.08%. Regarding short-term risk, MAHN is more volatile compared to PAOG. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check PAOG's competition here
MAHN vs SLHPF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, SLHPF has a market cap of 3.9K. Regarding current trading prices, MAHN is priced at $0.00, while SLHPF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas SLHPF's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to SLHPF's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to SLHPF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check SLHPF's competition here
MAHN vs WEQL Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, WEQL has a market cap of 3.5K. Regarding current trading prices, MAHN is priced at $0.00, while WEQL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas WEQL's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to WEQL's ROE of +0.21%. Regarding short-term risk, MAHN is more volatile compared to WEQL. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check WEQL's competition here
MAHN vs BBAL Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BBAL has a market cap of 3.4K. Regarding current trading prices, MAHN is priced at $0.00, while BBAL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BBAL's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to BBAL's ROE of +0.45%. Regarding short-term risk, MAHN is more volatile compared to BBAL. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BBAL's competition here
MAHN vs NMMCF Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, NMMCF has a market cap of 2.1K. Regarding current trading prices, MAHN is priced at $0.00, while NMMCF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas NMMCF's P/E ratio is 0.00. In terms of profitability, MAHN's ROE is N/A, compared to NMMCF's ROE of +0.00%. Regarding short-term risk, MAHN is more volatile compared to NMMCF. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check NMMCF's competition here
MAHN vs PPRG Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, PPRG has a market cap of 1.6K. Regarding current trading prices, MAHN is priced at $0.00, while PPRG trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas PPRG's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to PPRG's ROE of -0.58%. Regarding short-term risk, MAHN is more volatile compared to PPRG. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check PPRG's competition here
MAHN vs OHAQ Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, OHAQ has a market cap of 1.4K. Regarding current trading prices, MAHN is priced at $0.00, while OHAQ trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas OHAQ's P/E ratio is 0.01. In terms of profitability, MAHN's ROE is N/A, compared to OHAQ's ROE of +0.09%. Regarding short-term risk, MAHN is more volatile compared to OHAQ. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check OHAQ's competition here
MAHN vs BNKL Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, BNKL has a market cap of 1.2K. Regarding current trading prices, MAHN is priced at $0.00, while BNKL trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas BNKL's P/E ratio is N/A. In terms of profitability, MAHN's ROE is N/A, compared to BNKL's ROE of -7.69%. Regarding short-term risk, MAHN is more volatile compared to BNKL. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check BNKL's competition here
MAHN vs LHRP Comparison July 2025
MAHN plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, MAHN stands at 1.2K. In comparison, LHRP has a market cap of 340. Regarding current trading prices, MAHN is priced at $0.00, while LHRP trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
MAHN currently has a P/E ratio of 0.05, whereas LHRP's P/E ratio is 0.00. In terms of profitability, MAHN's ROE is N/A, compared to LHRP's ROE of N/A. Regarding short-term risk, MAHN is more volatile compared to LHRP. This indicates potentially higher risk in terms of short-term price fluctuations for MAHN.Check LHRP's competition here